
GLP‑1 is no longer just a weight‑loss story – it’s a full‑scale reset for food & beverage
Emerging research suggests GLP-1 drugs could move beyond diabetes and metabolic health to treat multiple diseases, meaning millions more consumers will rethink how – and what – they eat
















































